ION260 / Ionis, Biogen - LARVOL DELTA

A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 (clinicaltrials.gov) - P1 | N=8 | Terminated | Sponsor: Biogen | Active, not recruiting ➔ Terminated; Sponsor's Decision

Trial termination • Ataxia • Movement Disorders • ATXN3

A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 (clinicaltrials.gov) - P1 | N=8 | Active, not recruiting | Sponsor: Biogen | Recruiting ➔ Active, not recruiting | N=48 ➔ 8 | Trial completion date: Dec 2025 ➔ Jul 2023 | Trial primary completion date: Dec 2025 ➔ Jul 2023

Enrollment change • Enrollment closed • Trial completion date • Trial primary completion date • Ataxia • Movement Disorders • ATXN3